Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
European Journal of Medicinal Chemistry|March 2, 2017
Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agentsManikanta Murahari, Prashant S Kharkar, Nitin Lonikar, et al.Life (Basel, Switzerland)|June 28, 2023
Virtual Screening of a Marine Natural Product Database for In Silico Identification of a Potential Acetylcholinesterase InhibitorAnushree Chandrashekhar Gade, Manikanta Murahari, Parasuraman Pavadai, et al.European Journal of Medicinal Chemistry|September 9, 2017
Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studiesManikanta Murahari, Karanam Vanitha Prakash, Godefridus J Peters, et al.Archiv Der Pharmazie|April 24, 2019
Synthesis of novel gefitinib-based derivatives and their anticancer activityMrunal J Sharma, Maushmi S Kumar, Manikanta Murahari, et al.Journal of Microencapsulation|June 14, 2019
Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studiesShivalingappa Santhosh, Dhrubojyoti Mukherjee, Jayaraman Anbu, et al.Computers in Biology and Medicine|May 7, 2021
Structure-based design approach of potential BCL-2 inhibitors for cancer chemotherapySwati Krishna, S Birendra Kumar, T P Krishna Murthy, et al.Bioorganic Chemistry|February 21, 2019
Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitorsManikanta Murahari, Vivek Mahajan, Sreenivasulu Neeladri, et al.Journal of Biomolecular Structure & Dynamics|March 24, 2021
In silico screening of therapeutic potentials from Strychnos nux-vomica against the dimeric main protease (Mpro) structure of SARS-CoV-2Birendra Kumar, P Parasuraman, Thirupathihalli Pandurangappa Krishna Murthy, et al.Journal of Molecular Graphics & Modelling|January 3, 2022
Studies on ligand-based pharmacophore modeling approach in identifying potent future EGFR inhibitorsGulam Moin Shaikh, Manikanta Murahari, Shikha Thakur, et al.Molecular Diversity|April 28, 2022
Computational design of MmpL3 inhibitors for tuberculosis therapyR Chaitra, Rohit Gandhi, N Jayanna, et al.Pageof 4